A Danhong Injection, a blood activating and stasis resolving drug, can significantly reduce the levels of IL-6, TNF, and IL-8 in the serum of blood stasis rats, as well as inhibit inflammation and platelet aggregation, thereby reducing the immune response and peroxidation, protecting vascular endothelium and organ function, and preventing and treating cardiovascular diseases [15]. The gene discussed is CXCL8; the disease is cardiovascular disorder.